Literature DB >> 23946333

Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis.

A Serrano1, A Márquez1, S L Mackie2, F D Carmona1, R Solans3, J A Miranda-Filloy4, J Hernández-Rodríguez5, M C Cid5, S Castañeda6, I C Morado7, J Narváez8, R Blanco9, B Sopeña10, M J García-Villanueva11, J Monfort12, N Ortego-Centeno13, A Unzurrunzaga14, B Marí-Alfonso15, J Sánchez Martín16, E de Miguel17, C Magro18, E Raya18, N Braun19, J Latus19, O Molberg20, B A Lie21,22, F Moosig23, T Witte24, A W Morgan2, M A González-Gay9, J Martín1.   

Abstract

OBJECTIVE: To analyse the role of the PTPN22 and CSK genes, previously associated with autoimmunity, in the predisposition and clinical phenotypes of giant cell arteritis (GCA).
METHODS: Our study population was composed of 911 patients diagnosed with biopsy-proven GCA and 8136 unaffected controls from a Spanish discovery cohort and three additional independent replication cohorts from Germany, Norway and the UK. Two functional PTPN22 polymorphisms (rs2476601/R620W and rs33996649/R263Q) and two variants of the CSK gene (rs1378942 and rs34933034) were genotyped using predesigned TaqMan assays.
RESULTS: The analysis of the discovery cohort provided evidence of association of PTPN22 rs2476601/R620W with GCA (PFDR=1.06E-04, OR=1.62, CI 95% 1.29 to 2.04). The association did not appear to follow a specific GCA subphenotype. No statistically significant differences between allele frequencies for the other PTPN22 and CSK genetic variants were evident either in the case/control or in stratified case analysis. To confirm the detected PTPN22 association, three replication cohorts were genotyped, and a consistent association between the PTPN22 rs2476601/R620W variant and GCA was evident in the overall meta-analysis (PMH=2.00E-06, OR=1.51, CI 95% 1.28 to 1.79).
CONCLUSIONS: Our results suggest that the PTPN22 polymorphism rs2476601/R620W plays an important role in the genetic risk to GCA.

Entities:  

Keywords:  Gene Polymorphism; Giant Cell Arteritis; Polymyalgia Rheumatica

Mesh:

Substances:

Year:  2013        PMID: 23946333      PMCID: PMC4053592          DOI: 10.1136/annrheumdis-2013-203641

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  19 in total

Review 1.  Pathogenesis of giant cell arteritis: More than just an inflammatory condition?

Authors:  Kim-Heang Ly; Alexis Régent; Mathieu C Tamby; Luc Mouthon
Journal:  Autoimmun Rev       Date:  2010-05-08       Impact factor: 9.754

2.  The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples.

Authors:  Luis Rodríguez-Rodríguez; Wan Rohani Wan Taib; Ruth Topless; Sophia Steer; María F González-Escribano; Alejandro Balsa; Dora Pascual-Salcedo; Miguel A González-Gay; Enrique Raya; Benjamín Fernandez-Gutierrez; Isidoro González-Álvaro; Nunzio Bottini; Torsten Witte; Marte K Viken; Marieke J H Coenen; Piet L C M van Riel; Barbara Franke; Martin den Heijer; Timothy R D J Radstake; Paul Wordsworth; Benedicte A Lie; Tony R Merriman; Javier Martín
Journal:  Arthritis Rheum       Date:  2011-02

3.  PTPN22 R620W polymorphism in the ANCA-associated vasculitides.

Authors:  Davide Martorana; Federica Maritati; Giovanni Malerba; Francesco Bonatti; Federico Alberici; Elena Oliva; Paola Sebastio; Lucio Manenti; Rachele Brugnano; Maria G Catanoso; Paolo Fraticelli; Giuseppe Guida; Gina Gregorini; Stefano Possenti; Gabriella Moroni; Antonio Leoni; Laura Pavone; Alberto Pesci; Renato A Sinico; Lucafrancesco Di Toma; Marco D'Amico; Bruno Tumiati; Raffaele D'Ippolito; Carlo Buzio; Tauro M Neri; Augusto Vaglio
Journal:  Rheumatology (Oxford)       Date:  2012-01-11       Impact factor: 7.580

4.  Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Gisela Orozco; Elena Sánchez; Miguel A González-Gay; Miguel A López-Nevot; Belén Torres; Rafael Cáliz; Norberto Ortego-Centeno; Juan Jiménez-Alonso; Dora Pascual-Salcedo; Alejandro Balsa; Rosario de Pablo; Antonio Nuñez-Roldan; Maria Francisca González-Escribano; Javier Martín
Journal:  Arthritis Rheum       Date:  2005-01

5.  Reevaluation of the interaction between HLA-DRB1 shared epitope alleles, PTPN22, and smoking in determining susceptibility to autoantibody-positive and autoantibody-negative rheumatoid arthritis in a large UK Caucasian population.

Authors:  Ann W Morgan; Wendy Thomson; Stephen G Martin; Angela M Carter; Henry A Erlich; Anne Barton; Lynne Hocking; David M Reid; Pille Harrison; Paul Wordsworth; Sophia Steer; Jane Worthington; Paul Emery; Anthony G Wilson; Jennifer H Barrett
Journal:  Arthritis Rheum       Date:  2009-09

6.  The association of the PTPN22 620W polymorphism with Behcet's disease.

Authors:  Vijay Baranathan; Miles R Stanford; Robert W Vaughan; Elli Kondeatis; Elizabeth Graham; Farida Fortune; Wafa Madanat; Charlie Kanawati; Marwen Ghabra; Philip I Murray; Graham R Wallace
Journal:  Ann Rheum Dis       Date:  2007-07-27       Impact factor: 19.103

7.  Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up.

Authors:  Jose-Ezequiel Martin; Jasper C Broen; F David Carmona; Maria Teruel; Carmen P Simeon; Madelon C Vonk; Ruben van 't Slot; Luis Rodriguez-Rodriguez; Esther Vicente; Vicente Fonollosa; Norberto Ortego-Centeno; Miguel A González-Gay; Francisco J García-Hernández; Paloma García de la Peña; Patricia Carreira; Alexandre E Voskuyl; Annemie J Schuerwegh; Piet L C M van Riel; Alexander Kreuter; Torsten Witte; Gabriella Riemekasten; Paolo Airo; Raffaella Scorza; Claudio Lunardi; Nicolas Hunzelmann; Jörg H W Distler; Lorenzo Beretta; Jacob van Laar; Meng May Chee; Jane Worthington; Ariane Herrick; Christopher Denton; Filemon K Tan; Frank C Arnett; Shervin Assassi; Carmen Fonseca; Maureen D Mayes; Timothy R D J Radstake; Bobby P C Koeleman; Javier Martin
Journal:  Hum Mol Genet       Date:  2012-03-09       Impact factor: 6.150

8.  Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant.

Authors:  Torkel Vang; Mauro Congia; Maria Doloretta Macis; Lucia Musumeci; Valeria Orrú; Patrizia Zavattari; Konstantina Nika; Lutz Tautz; Kjetil Taskén; Francesco Cucca; Tomas Mustelin; Nunzio Bottini
Journal:  Nat Genet       Date:  2005-11-06       Impact factor: 38.330

9.  CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation.

Authors:  Nataly Manjarrez-Orduño; Emiliano Marasco; Sharon A Chung; Matthew S Katz; Jenna F Kiridly; Kim R Simpfendorfer; Jan Freudenberg; David H Ballard; Emil Nashi; Thomas J Hopkins; Deborah S Cunninghame Graham; Annette T Lee; Marieke J H Coenen; Barbara Franke; Dorine W Swinkels; Robert R Graham; Robert P Kimberly; Patrick M Gaffney; Timothy J Vyse; Timothy W Behrens; Lindsey A Criswell; Betty Diamond; Peter K Gregersen
Journal:  Nat Genet       Date:  2012-10-07       Impact factor: 38.330

10.  Structural basis for the recognition of c-Src by its inactivator Csk.

Authors:  Nicholas M Levinson; Markus A Seeliger; Philip A Cole; John Kuriyan
Journal:  Cell       Date:  2008-07-11       Impact factor: 41.582

View more
  17 in total

Review 1.  The Contribution of PTPN22 to Rheumatic Disease.

Authors:  Tomas Mustelin; Nunzio Bottini; Stephanie M Stanford
Journal:  Arthritis Rheumatol       Date:  2019-03-02       Impact factor: 10.995

Review 2.  Revisited HLA and non-HLA genetics of Takayasu arteritis--where are we?

Authors:  Chikashi Terao
Journal:  J Hum Genet       Date:  2015-07-16       Impact factor: 3.172

Review 3.  PTPN22: the archetypal non-HLA autoimmunity gene.

Authors:  Stephanie M Stanford; Nunzio Bottini
Journal:  Nat Rev Rheumatol       Date:  2014-07-08       Impact factor: 20.543

4.  Association of PTPN22 polymorphsims and ankylosing spondylitis susceptibility.

Authors:  Qingxi Meng; Xiaojun Zhang; Xin Liu; Weiguo Wang; Peng Yu; Qunqun Shan; Zhaohu Mao; Tingbao Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

Review 5.  Giant cell arteritis and polymyalgia rheumatica: an update.

Authors:  Miguel A González-Gay; Trinitario Pina
Journal:  Curr Rheumatol Rep       Date:  2015-02       Impact factor: 4.592

Review 6.  Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management.

Authors:  Giorgio Trivioli; Ana Marquez; Davide Martorana; Michelangelo Tesi; Andreas Kronbichler; Paul A Lyons; Augusto Vaglio
Journal:  Nat Rev Rheumatol       Date:  2022-09-15       Impact factor: 32.286

Review 7.  Large-vessel vasculitis.

Authors:  Dan Pugh; Maira Karabayas; Neil Basu; Maria C Cid; Ruchika Goel; Carl S Goodyear; Peter C Grayson; Stephen P McAdoo; Justin C Mason; Catherine Owen; Cornelia M Weyand; Taryn Youngstein; Neeraj Dhaun
Journal:  Nat Rev Dis Primers       Date:  2022-01-06       Impact factor: 65.038

8.  A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis.

Authors:  F David Carmona; Augusto Vaglio; Sarah L Mackie; José Hernández-Rodríguez; Paul A Monach; Santos Castañeda; Roser Solans; Inmaculada C Morado; Javier Narváez; Marc Ramentol-Sintas; Colin T Pease; Bhaskar Dasgupta; Richard Watts; Nader Khalidi; Carol A Langford; Steven Ytterberg; Luigi Boiardi; Lorenzo Beretta; Marcello Govoni; Giacomo Emmi; Francesco Bonatti; Marco A Cimmino; Torsten Witte; Thomas Neumann; Julia Holle; Verena Schönau; Laurent Sailler; Thomas Papo; Julien Haroche; Alfred Mahr; Luc Mouthon; Øyvind Molberg; Andreas P Diamantopoulos; Alexandre Voskuyl; Elisabeth Brouwer; Thomas Daikeler; Christoph T Berger; Eamonn S Molloy; Lorraine O'Neill; Daniel Blockmans; Benedicte A Lie; Paul Mclaren; Timothy J Vyse; Cisca Wijmenga; Yannick Allanore; Bobby P C Koeleman; Jennifer H Barrett; María C Cid; Carlo Salvarani; Peter A Merkel; Ann W Morgan; Miguel A González-Gay; Javier Martín
Journal:  Am J Hum Genet       Date:  2016-12-29       Impact factor: 11.025

9.  A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.

Authors:  F David Carmona; Sarah L Mackie; Jose-Ezequiel Martín; John C Taylor; Augusto Vaglio; Stephen Eyre; Lara Bossini-Castillo; Santos Castañeda; Maria C Cid; José Hernández-Rodríguez; Sergio Prieto-González; Roser Solans; Marc Ramentol-Sintas; M Francisca González-Escribano; Lourdes Ortiz-Fernández; Inmaculada C Morado; Javier Narváez; José A Miranda-Filloy; Lorenzo Beretta; Claudio Lunardi; Marco A Cimmino; Davide Gianfreda; Daniele Santilli; Giuseppe A Ramirez; Alessandra Soriano; Francesco Muratore; Giulia Pazzola; Olga Addimanda; Cisca Wijmenga; Torsten Witte; Jan H Schirmer; Frank Moosig; Verena Schönau; Andre Franke; Øyvind Palm; Øyvind Molberg; Andreas P Diamantopoulos; Simon Carette; David Cuthbertson; Lindsy J Forbess; Gary S Hoffman; Nader A Khalidi; Curry L Koening; Carol A Langford; Carol A McAlear; Larry Moreland; Paul A Monach; Christian Pagnoux; Philip Seo; Robert Spiera; Antoine G Sreih; Kenneth J Warrington; Steven R Ytterberg; Peter K Gregersen; Colin T Pease; Andrew Gough; Michael Green; Lesley Hordon; Stephen Jarrett; Richard Watts; Sarah Levy; Yusuf Patel; Sanjeet Kamath; Bhaskar Dasgupta; Jane Worthington; Bobby P C Koeleman; Paul I W de Bakker; Jennifer H Barrett; Carlo Salvarani; Peter A Merkel; Miguel A González-Gay; Ann W Morgan; Javier Martín
Journal:  Am J Hum Genet       Date:  2015-03-26       Impact factor: 11.025

10.  Role of PTPN22 and CSK gene polymorphisms as predictors of susceptibility and clinical heterogeneity in patients with Henoch-Schönlein purpura (IgA vasculitis).

Authors:  Raquel López-Mejías; Fernanda Genre; Sara Remuzgo-Martínez; Belén Sevilla Pérez; Santos Castañeda; Javier Llorca; Norberto Ortego-Centeno; Begoña Ubilla; Verónica Mijares; Trinitario Pina; Vanesa Calvo-Río; Natalia Palmou; José A Miranda-Filloy; Antonio Navas Parejo; Diego Argila; Javier Sánchez-Pérez; Esteban Rubio; Manuel León Luque; Juan María Blanco-Madrigal; Eva Galíndez-Aguirregoikoa; J Gonzalo Ocejo-Vinyals; Javier Martín; Ricardo Blanco; Miguel A González-Gay
Journal:  Arthritis Res Ther       Date:  2015-10-13       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.